| Characteristic | Overall N = 2381 |
CCS N = 1141 |
ACS N = 1241 |
p-value2 |
|---|---|---|---|---|
| Wiek, lata | 80.0 (77.0, 84.0) | 79.0 (76.0, 82.0) | 81.5 (77.0, 86.0) | <0.001 |
| Płeć żeńska | 0.7 | |||
| Nie | 135 / 238 (57%) | 66 / 114 (58%) | 69 / 124 (56%) | |
| Tak | 103 / 238 (43%) | 48 / 114 (42%) | 55 / 124 (44%) | |
| BMI, kg/m² | 27.7 (24.5, 31.5) | 29.0 (25.6, 32.0) | 26.7 (24.0, 30.8) | 0.019 |
| Brak danych | 7 | 1 | 6 | |
| Cukrzyca | 0.6 | |||
| Nie | 148 / 238 (62%) | 73 / 114 (64%) | 75 / 124 (60%) | |
| Tak | 90 / 238 (38%) | 41 / 114 (36%) | 49 / 124 (40%) | |
| Leczenie insuliną | 0.5 | |||
| Nie | 210 / 234 (90%) | 103 / 113 (91%) | 107 / 121 (88%) | |
| Tak | 24 / 234 (10%) | 10 / 113 (8.8%) | 14 / 121 (12%) | |
| Brak danych | 4 | 1 | 3 | |
| Migotanie przedsionków | 0.087 | |||
| Nie | 175 / 238 (74%) | 78 / 114 (68%) | 97 / 124 (78%) | |
| Tak | 63 / 238 (26%) | 36 / 114 (32%) | 27 / 124 (22%) | |
| Nadciśnienie tętnicze | 0.7 | |||
| Nie | 57 / 238 (24%) | 26 / 114 (23%) | 31 / 124 (25%) | |
| Tak | 181 / 238 (76%) | 88 / 114 (77%) | 93 / 124 (75%) | |
| Przebyty udar/TIA | 0.6 | |||
| Nie | 219 / 238 (92%) | 106 / 114 (93%) | 113 / 124 (91%) | |
| Tak | 19 / 238 (8.0%) | 8 / 114 (7.0%) | 11 / 124 (8.9%) | |
| Przebyty zawał serca | 0.3 | |||
| Nie | 205 / 238 (86%) | 101 / 114 (89%) | 104 / 124 (84%) | |
| Tak | 33 / 238 (14%) | 13 / 114 (11%) | 20 / 124 (16%) | |
| Niewydolność nerek | 0.2 | |||
| Nie | 207 / 238 (87%) | 96 / 114 (84%) | 111 / 124 (90%) | |
| Tak | 31 / 238 (13%) | 18 / 114 (16%) | 13 / 124 (10%) | |
| Dializy przewlekłe | >0.9 | |||
| Nie | 228 / 234 (97%) | 110 / 113 (97%) | 118 / 121 (98%) | |
| Tak | 6 / 234 (2.6%) | 3 / 113 (2.7%) | 3 / 121 (2.5%) | |
| Brak danych | 4 | 1 | 3 | |
| POCHP | 0.2 | |||
| Nie | 222 / 238 (93%) | 104 / 114 (91%) | 118 / 124 (95%) | |
| Tak | 16 / 238 (6.7%) | 10 / 114 (8.8%) | 6 / 124 (4.8%) | |
| PAD | 0.5 | |||
| Nie | 226 / 238 (95%) | 107 / 114 (94%) | 119 / 124 (96%) | |
| Tak | 12 / 238 (5.0%) | 7 / 114 (6.1%) | 5 / 124 (4.0%) | |
| Przebyte PCI | >0.9 | |||
| Nie | 163 / 235 (69%) | 79 / 114 (69%) | 84 / 121 (69%) | |
| Tak | 72 / 235 (31%) | 35 / 114 (31%) | 37 / 121 (31%) | |
| Brak danych | 3 | 0 | 3 | |
| LVEF, % | 50 (40, 55) | 50 (45, 55) | 45 (38, 55) | 0.3 |
| Brak danych | 58 | 33 | 25 | |
| GFR MDRD, ml/min/1,73 m² | 64 (48, 79) | 66 (50, 82) | 62 (47, 76) | 0.2 |
| Brak danych | 1 | 1 | 0 | |
| Liczba zwężonych naczyń | 0.9 | |||
| 1 | 46 / 238 (19%) | 22 / 114 (19%) | 24 / 124 (19%) | |
| 2 | 72 / 238 (30%) | 38 / 114 (33%) | 34 / 124 (27%) | |
| 3 | 63 / 238 (26%) | 27 / 114 (24%) | 36 / 124 (29%) | |
| 4 | 41 / 238 (17%) | 19 / 114 (17%) | 22 / 124 (18%) | |
| 5 | 13 / 238 (5.5%) | 6 / 114 (5.3%) | 7 / 124 (5.6%) | |
| 6 | 3 / 238 (1.3%) | 2 / 114 (1.8%) | 1 / 124 (0.8%) | |
| Zajęcie pnia lewej tętnicy wieńcowej | 0.3 | |||
| Nie | 198 / 238 (83%) | 98 / 114 (86%) | 100 / 124 (81%) | |
| Tak | 40 / 238 (17%) | 16 / 114 (14%) | 24 / 124 (19%) | |
| CTO | 0.8 | |||
| Nie | 183 / 238 (77%) | 87 / 114 (76%) | 96 / 124 (77%) | |
| Tak | 55 / 238 (23%) | 27 / 114 (24%) | 28 / 124 (23%) | |
| 1 Median (Q1, Q3); n / N (%) | ||||
| 2 Wilcoxon rank sum test; Pearson’s Chi-squared test; Fisher’s exact test | ||||